The US Supreme Court will allow a drug used in more than half of the country’s abortions to remain available while a legal fight over its decades-long regulatory approval plays out in lower courts.
The court on Friday halted a ruling by Texas federal judge Matthew Kacsmaryk, who earlier this month suspended the authorisation of mifepristone while the appeals process runs its course.
The move is a win for the US government and pharmaceutical sector in their legal fight over the abortion drug. Both the Department of Justice and Danco Laboratories, which makes mifepristone, challenged the Texas ruling, which suspended regulatory approval for mifepristone granted more than 20 years ago, in effect leading to a nationwide ban.
您已閱讀17%（731字），剩餘83%（3526字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。